MARKET

HRTX

HRTX

Heron Therapeutics Inc
NASDAQ
1.140
+0.030
+2.70%
After Hours: 1.140 0 0.00% 18:05 06/07 EDT
OPEN
1.120
PREV CLOSE
1.110
HIGH
1.160
LOW
1.115
VOLUME
1.29M
TURNOVER
0
52 WEEK HIGH
5.62
52 WEEK LOW
1.070
MARKET CAP
136.47M
P/E (TTM)
-0.8339
1D
5D
1M
3M
1Y
5Y
Heron Therapeutics Inc: Statement of changes in beneficial ownership of securities
Press release · 05/25 00:05
XBiotech, Impel top healthcare gainers; Intercept, Agile among losers
Seeking Alpha · 05/17 14:03
Disastrous Earnings Report Takes Down Heron Therapeutics
TipRanks · 05/12 21:01
Nasdaq Down 100 Points; Crude Oil Drops Over 1%
Benzinga · 05/12 18:30
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 05/12 17:31
AQST, GSTI and APYX among mid-day movers
Seeking Alpha · 05/12 17:14
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 05/12 17:09
Heron Therapeutics (HRTX) Gets a Buy from Needham
TipRanks · 05/12 16:25
More
About HRTX
Heron Therapeutics, Inc. is a commercial-stage biotechnology company. The Company commercializes a portfolio of products to care for acute care and oncology patients. Its oncology care product portfolio includes SUSTOL and CINVANTI. SUSTOL is used for the prevention of acute and delayed nausea and vomiting associated with both moderately emetogenic chemotherapy (MEC), and anthracycline and cyclophosphamide (AC) combination chemotherapy regimens. CINVANTI is an intravenous (IV) formulation of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist. Its acute care product portfolio includes ZYNRELEF, HTX-019, and HTX-034. HTX- ZYNRELEF is a dual-acting local anaesthetic that delivers a fixed-dose combination of the local anaesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam. HTX-019 is an investigational agent for the prevention of postoperative nausea and vomiting in adults. HTX-034 is a product candidate for postoperative pain management.

Webull offers kinds of Heron Therapeutics Inc stock information, including NASDAQ:HRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HRTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HRTX stock methods without spending real money on the virtual paper trading platform.